Bexarotene
- TRADE NAME: Targretin (Eisai)
- INDICATIONS: Cutaneous T-cell lymphoma (CTCL), mycosis fungoides
- CLASS: Retinoid, Antineoplastic
- HALF-LIFE: 7 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Acitretin, Atorvastatin, Beta-Carotene, Carboplatin, Conivaptan, Dexamethasone, Dong Quai, Gemfibrozil, Grapefruit juice, Isotretinoin, Oral contraceptives, Paclitaxel, Saxagliptin, St John's Wort, Tamoxifen, Tetracyclines, Tretinoin, Vitamin A
PREGNANCY CATEGORY: X
Retinoids can cause birth defects, and women should avoid bexarotene when pregnant or trying to conceive.
Please login to see the rest of this drug profile
SKIN
HAIR
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
RESPIRATORY
ENDOCRINE/METABOLIC
GENITOURINARY
RENAL
HEMATOLOGIC
OTIC
OCULAR
OTHER
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life Threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric